- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
In a statement this afternoon, Quebec’s Health Department announced that the AstraZeneca vaccine “will no longer be given to people under the age of 55, until further notice.”
The decision was made “in concert with the Public Health Agency of Canada and other Canadian provinces and follows the recommendations of the National Advisory Committee on Immunization and
the Committee on Immunization of Quebec.”
The department notes that European authorities are “currently evaluating a potential link between certain health complications and AstraZeneca’s vaccine in people under the age of 55.
The European Medicines Agency “still considers this product to be safe and effective, but the possibility of a link between the vaccine and bleeding disorders and cerebral venous thrombosis
cannot be completely ruled out at this time,” the department said.
“Very rare cases have occurred within weeks of receiving AstraZeneca vaccine in some European countries, the majority in women under 55 years of age. However, it is not possible to determine
at this stage whether the events are related to the person’s gender.”
Quebec emphasized that no “thrombosis linked to the vaccine has been reported in Canada. To date, 111,000 doses of this vaccine have been administered in Quebec. Close monitoring continues.”
The health department said that “rare unwanted symptoms usually occur within days of vaccination.
“A person who has recently been vaccinated should consult a doctor quickly or contact Info-Santé if they observe these symptoms in the days following vaccination: severe or persistent
headaches, blurred vision, chest pain, swelling of the legs, persistent abdominal pain, cloudy vision or bruising on the skin.”
